Page last updated: 2024-11-07

enterocin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

enterocin: antibiotic isolated from Streptomyces candidus var. enterostaticus WS-8096 & Streptomyces viridochromogenes M-127; molecular formula: C22-H20-010; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID146159291
MeSH IDM0059257

Synonyms (3)

Synonym
vulgamycin
59678-46-5
enterocin

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The results obtained indicate possible safe use of enterocin S37 in the gastrointestinal tract of animals to prevent pathogen invasion and/or infection."( Growing insights into the safety of bacteriocins: the case of enterocin S37.
Belguesmia, Y; Connil, N; Drider, D; Feuilloley, M; Madi, A; Merieau, A; Prévost, H; Sperandio, D,
)
0.13
" This study highlights safe Enterococcus lactis strains with great technological and probiotic potentials for future application as new starter, adjunct, protective or probiotic cultures in food industry."( Safety, potential biotechnological and probiotic properties of bacteriocinogenic Enterococcus lactis strains isolated from raw shrimps.
Ben Braïek, O; Cremonesi, P; Ghrairi, T; Hani, K; Morandi, S; Smaoui, S, 2018
)
0.48
" Therefore, it may be useful as a safe natural agent in preservation of foods or as a new probiotic strain in food and feed."( Safety characterisation and inhibition of fungi and bacteria by a novel multiple enterocin-producing Enterococcus lactis 4CP3 strain.
Ben Braïek, O; Cremonesi, P; Ghrairi, T; Hani, K; Morandi, S; Smaoui, S, 2018
)
0.48

Compound-Compound Interactions

ExcerptReferenceRelevance
" coli O157:H7 in combination with other hurdles."( Synergistic effect of enterocin AS-48 in combination with outer membrane permeabilizing treatments against Escherichia coli O157:H7.
Ananou, S; Gálvez, A; Maqueda, M; Martínez-Bueno, M; Valdivia, E, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (134)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.49)18.7374
1990's9 (6.72)18.2507
2000's40 (29.85)29.6817
2010's44 (32.84)24.3611
2020's39 (29.10)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (6.62%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other127 (93.38%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]